TOKYO (Reuters) -U.S. private equity firm KKR has sweetened its offer for Japan's Fuji Soft by 4%, the latest salvo in its protracted and messy bidding war with Bain Capital for the $4 billion IT ...

KKR & Co's fourth-quarter assets under management fell short of expectations on Tuesday, dampening the optimism around strength in its capital markets business and sending the company's shares to a ...

With public and private markets converging, says KKR & Co., a seismic shift is happening that will make 2025 credit’s “iPhone moment.” “The launch of the iPhone wasn’t just the debut of ...

KKR reported an adjusted EPS of $1.32, higher than the estimated $1.28. Revenue reached $3.26 billion, surpassing the expected $1.96 billion. Fee-related earnings grew by 25% year over year to $ ...

KKR (NYSE:KKR) has agreed to acquire Milton Keynes, U.K.-based asset leasing platform, Dawsongroup. The transaction is subject to the receipt of regulatory approvals. The acquisition will be made ...

Company's fee-related earnings also miss expectations Stock down 8.5% KKR set to increase ownership in three existing private equity investments Feb 4 (Reuters) - KKR & Co's (KKR.N), opens new tab ...

KKR & Co.’s business of arranging financing for its portfolio companies and other firms reported record annual fees last year, driven by growth in structured-credit transactions. The capital ...

Your browser does not support the audio element. BMW has launched the updated S 1000 RR, with prices starting at Rs 21.20 lakh, at the Bharat Mobility Global Expo ...

TOKYO : U.S. private equity fund KKR will raise its tender offer price for Fuji Soft shares to 9,850 yen per share from 9,451 yen, above Bain Capital's rival offer of 9,600 yen, the Nikkei ...

SINGAPORE, Jan 17 (Reuters) - Global investment firm KKR (KKR.N), opens new tab has appointed Goldman Sachs (GS.N), opens new tab for the sale of its significant minority stake in Philippine ...

WASHINGTON (Reuters) -The U.S. filed a civil lawsuit on Tuesday against private equity firm KKR & Co, "for repeatedly flouting the premerger antitrust review process," alleging the company avoided ...

Private equity firm KKR will start the process of exiting and selling its stake in portfolio firm JB Chemicals and Pharmaceuticals through block deals later in the year, sources with knowledge of ...